Below are the financial statements of Ono Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of JPY | 2024 | 2023 |
|---|---|---|
| Revenue | 502,672a | 447,187a |
| Cost of sales | -127,126a | -110,062a |
| Gross profit | 375,547a | 337,124a |
| Selling, general, and administrative expenses | -100,270a | -89,486a |
| Research and development expenses | -112,174a | -95,344a |
| Other income | 1,176a | 734a |
| Other expenses | -4,343a | -11,065a |
| Operating profit | 159,935a | 141,963a |
| Finance income | 4,027a | 2,478a |
| Finance costs | -229a | -913a |
| Share of profit (loss) from investments in associates | 1a | 4a |
| Profit before tax | 163,734a | 143,532a |
| Income tax expense | -35,694a | -30,619a |
| Profit for the year | 128,040a | 112,913a |
| Profit for the year attributable to | — | — |
| Owners of the parent company | 127,977a | 112,723a |
| Non-controlling interests | 62a | 190a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ono Pharmaceutical’s data sources below and access millions more through our Disclosure Search.